Krivak, T. C., Darcy, K. M., Tian, C., Armstrong, D., Baysal, B. E., Gallion, H., . . . DeLoia, J. A. (2008). Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer. J Clin Oncol.

Krivak, Thomas C., Kathleen M. Darcy, Chunqiao Tian, Deborah Armstrong, Bora E. Baysal, Holly Gallion, Christine B. Ambrosone, and Julie A. DeLoia. "Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer." J Clin Oncol 2008.

Krivak, Thomas C., et al. "Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer." J Clin Oncol 2008.